ArticleJournal of neuro-oncology2015

A preclinical study demonstrating the efficacy of nilotinib in inhibiting the growth of pediatric high-grade glioma.

Karolyn Au et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.